Anorexia/ Cachexia Clinical Trials & Research at Providence Medical Group

Providence Medical Group is currently enrolling patients for the following Anorexia/ Cachexia clinical trials:

Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15 (PROACC-1)

Treatment agent: Ponsegromab
PI: Sara Keck, MD
Study Coordinator: Melissa Phillips //Melissa.Phillips2@stjoe.org// (707) 521-3833
Resources and Links: https://clinicaltrials.gov/ct2/show/NCT05546476?term=NCT05546476&draw=2&rank=1
Sponsor: Pfizer